Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c127
Identifier NCT07138898
Trial Title Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Rheumatic Disease
Interventions DRUG: Methotrexate|DRUG: Sulfasalazine|DRUG: Hydroxychloroquine|DRUG: Leflunomide|DRUG: Azathioprine|DRUG: Mycophenolate|DRUG: Cyclosporine|DRUG: Tacrolimus|DRUG: Etanercept|DRUG: Adalimumab|DRUG: Golimumab|DRUG: Certolizumab|DRUG: Infliximab|BIOLOGICAL: Rituximab|BIOLOGICAL: Belimumab|BIOLOGICAL: Tocilizumab|BIOLOGICAL: Anakinra|BIOLOGICAL: Canakinumab|BIOLOGICAL: Abatacept|BIOLOGICAL: Secukinumab|BIOLOGICAL: Ixekizumab|BIOLOGICAL: Bimekizumab|BIOLOGICAL: Ustekinumab|BIOLOGICAL: Guselkumab|BIOLOGICAL: Risankizumab|DRUG: Tofacitinib|DRUG: Upadacitinib
Participant Information
Sponsor NYU Langone Health
City NYU Langone Health
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-09
Primary Completion Date 2027-09
Completion Date 2027-09